EBV BART miRNAs: Identification of Targets and Characterization of the Effects o

EBV BART miRNA:目标鉴定和效应表征

基本信息

项目摘要

DESCRIPTION (provided by applicant): The human tumor virus, Epstein Barr Virus (EBV), encodes multiple microRNAs (miRNAs) that are expressed during latent infection in tumors. Two groups of miRNAs have been identified. One group is only expressed in transformed lymphocytes in Type III latency. The second group containing two clusters is produced from a complex family of transcripts, termed BARTs, from the BamHI A region of the genome. Importantly, these transcripts are highly produced in EBV-associated tumors but are expressed at low levels in infected B-lymphoid cell lines. Several of the EBV miRNAS are highly conserved with those identified in rhesus EBV with considerably greater homology than EBV/KSHV coding sequences. This conservation of sequences suggests that the miRNAs might target cellular messages. Based on these findings, this application will test the hypothesis that the EBV BART miRNAs target cellular genes to affect growth regulation. The proposed experiments will use a combination of bioinformatic, microarray, and proteomics to identify the cellular targets of the BART miRNAs. Cell lines that stably express the BART miRNAs will be produced to confirm expression and to determine the effects of the miRNAs on cellular growth properties. Multiple cellular signaling pathways are affected by EBV transforming proteins so potential modulation of these pathways by the BART miRNAs will also be examined. The effects of loss of miRNA expression in EBV infected cells will be assessed using antagomirs, sponges, and inhibitors of miRNA synthesis. Cellular miRNAs have been shown to be major factors in the development of cancer. This proposal will determine how the EBV miRNAs contribute to EBV-mediated oncogenesis. PUBLIC HEALTH RELEVANCE: Infection with Epstein-Barr virus contributes to the development of several important human malignancies through the effects of viral proteins on cell growth regulation. A new form of growth regulation has been discovered that involves small RNAs (miRNAs) that affect the function of cellular genes and contribute to cancer. EBV encodes multiple miRNAs that we have shown to be expressed at high levels in some EBV-associated cancers particularly nasopharyngeal carcinoma. The identification of cellular proteins that are targeted by the EBV miRNAs will increase our understanding of how EBV contributes to the development of cancer.
描述(由申请人提供):人类肿瘤病毒,爱泼斯坦Barr病毒(EBV),编码在肿瘤潜在感染期间表达的多个microRNA(miRNA)。已经确定了两组miRNA。仅在III型潜伏期中转化的淋巴细胞中表达一组。第二组包含两个簇是由一个复杂的转录本,称为BART,来自基因组的BAMHI A区域。重要的是,这些转录本在与EBV相关的肿瘤中高度产生,但在感染的B淋巴样细胞系中以低水平表达。与EBV/KSHV编码序列相比,几种EBV miRNA具有高度保守的EBV miRNA。序列的保存表明miRNA可能靶向细胞信息。基于这些发现,该应用将检验以下假设:EBV BART miRNA靶基因影响生长调节。提出的实验将结合生物信息学,微阵列和蛋白质组学的组合来鉴定巴特miRNA的细胞靶标。稳定表达BART miRNA的细胞系将产生以确认表达并确定miRNA对细胞生长特性的影响。多个细胞信号通路受EBV转化蛋白的影响,因此还将检查BART miRNA对这些途径的潜在调节。将使用miRNA合成的Antagomirs,海绵和抑制剂评估miRNA表达丧失在EBV感染细胞中的影响。细胞miRNA已被证明是癌症发展的主要因素。该建议将决定EBV miRNA如何促进EBV介导的肿瘤发生。 公共卫生相关性:爱泼斯坦 - 巴尔病毒的感染通过病毒蛋白对细胞生长调节的影响有助于发展几种重要的人类恶性肿瘤。已经发现了一种新的生长调节形式,涉及影响细胞基因功能并有助于癌症功能的小RNA(miRNA)。 EBV编码多种miRNA,我们已证明在某些EBV相关的癌症(尤其是鼻咽癌)中以高水平表达。 EBV miRNA靶向的细胞蛋白的鉴定将增加我们对EBV如何促进癌症发展的理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NANCY JOAN RAAB-TRAUB其他文献

NANCY JOAN RAAB-TRAUB的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NANCY JOAN RAAB-TRAUB', 18)}}的其他基金

Virology
病毒学
  • 批准号:
    8340212
  • 财政年份:
    2011
  • 资助金额:
    $ 30.58万
  • 项目类别:
Virology
病毒学
  • 批准号:
    8340213
  • 财政年份:
    2011
  • 资助金额:
    $ 30.58万
  • 项目类别:
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o
EBV BART miRNA:目标鉴定和效应表征
  • 批准号:
    8386652
  • 财政年份:
    2009
  • 资助金额:
    $ 30.58万
  • 项目类别:
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o
EBV BART miRNA:目标鉴定和效应表征
  • 批准号:
    8585832
  • 财政年份:
    2009
  • 资助金额:
    $ 30.58万
  • 项目类别:
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o
EBV BART miRNA:目标鉴定和效应表征
  • 批准号:
    7995263
  • 财政年份:
    2009
  • 资助金额:
    $ 30.58万
  • 项目类别:
EBV BART miRNAs: Identification of Targets and Characterization of the Effects o
EBV BART miRNA:目标鉴定和效应表征
  • 批准号:
    8196870
  • 财政年份:
    2009
  • 资助金额:
    $ 30.58万
  • 项目类别:
Herpesviral Oncogenesis, Latency and Reactivation
疱疹病毒肿瘤发生、潜伏期和再激活
  • 批准号:
    7908032
  • 财政年份:
    2009
  • 资助金额:
    $ 30.58万
  • 项目类别:
ADMINISTRATION CORE
管理核心
  • 批准号:
    6930192
  • 财政年份:
    2005
  • 资助金额:
    $ 30.58万
  • 项目类别:
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEINS 1 AND 2
EBV 潜伏膜蛋白 1 和 2 的转化
  • 批准号:
    6930190
  • 财政年份:
    2005
  • 资助金额:
    $ 30.58万
  • 项目类别:
Epstein-Barr Virus: Activation of WNT
Epstein-Barr 病毒:WNT 激活
  • 批准号:
    7105558
  • 财政年份:
    2004
  • 资助金额:
    $ 30.58万
  • 项目类别:

相似海外基金

The role of RNA binding proteins in heart development and congenital heart defects
RNA结合蛋白在心脏发育和先天性心脏缺陷中的作用
  • 批准号:
    10827567
  • 财政年份:
    2023
  • 资助金额:
    $ 30.58万
  • 项目类别:
Muscle-Specific CRISPR/Cas9 Exon Skipping for Duchenne Muscular Dystrophy Therapeutics
肌肉特异性 CRISPR/Cas9 外显子跳跃用于杜氏肌营养不良疗法
  • 批准号:
    10679199
  • 财政年份:
    2023
  • 资助金额:
    $ 30.58万
  • 项目类别:
Modulation of RNA Binding Proteins in Xenobiotic-induced Hepatotoxicity
RNA 结合蛋白在异生素诱导的肝毒性中的调节
  • 批准号:
    10587498
  • 财政年份:
    2023
  • 资助金额:
    $ 30.58万
  • 项目类别:
High-throughput dissection of RNA localization regulatory elements
RNA 定位调控元件的高通量解析
  • 批准号:
    10749328
  • 财政年份:
    2023
  • 资助金额:
    $ 30.58万
  • 项目类别:
RNA Control of Neural Function
RNA 控制神经功能
  • 批准号:
    10622122
  • 财政年份:
    2023
  • 资助金额:
    $ 30.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了